All News

Making waves in breast cancer prevention

December 03, 2021

“This vaccine strategy has the potential to be applied to other tumor types,” said Vincent K. Tuohy, PhD, the Mort and Iris November Distinguished Chair in Innovative Breast Cancer Research at Cleveland Clinic Lerner Research Institute, and primary inventor of the vaccine.

S3E20: Brooke Faught, NP on sexual health, trauma-informed care, and the perks of meeting in-person

December 03, 2021

In this episode of Pap Talk, we took you with us to the North American Menopause Society's recent Annual Meeting. Sexual health specialist Michael Krychman, MD, sat down with Brooke Faught, NP, to learn more about her work at the Women's Institute for Sexual Health, her role on the NAMS Planning Committee, and her tips for talking trauma with patients.

Laser for postmenopausal vaginal symptoms

December 02, 2021

For women with postmenopausal vaginal symptoms, fractional carbon dioxide laser versus sham treatment fails to significantly improve vaginal symptoms after 12 months, according to the results of a randomized controlled trial in JAMA.

Retifanlimab shows promising antitumor activity in advanced endometrial cancer

December 01, 2021

Retifanlimab demonstrated encouraging antitumor activity with favorable tolerability in patients with recurrent microsatellite instability–high or mismatch repair deficient endometrial cancer, according to data from the phase 1 POD1UM-101 trial.